Tudor Investment Corp’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,086
Closed -$120K 3527
2025
Q2
$120K Sell
24,086
-116,252
-83% -$505K ﹤0.01% 3146
2025
Q1
$619K Buy
+140,338
New +$659K ﹤0.01% 2143
2024
Q3
Sell
-131,277
Closed -$1.02M 2846
2024
Q2
$1.02M Sell
131,277
-296,665
-69% -$2.2M 0.01% 1448
2024
Q1
$3.04M Buy
+427,942
New +$2.83M 0.02% 826
2023
Q4
Sell
-30,460
Closed -$171K 2548
2023
Q3
$171K Buy
+30,460
New +$203K ﹤0.01% 2108
2023
Q2
Sell
-169,187
Closed -$1.06M 2618
2023
Q1
$1.06M Sell
169,187
-120,879
-42% -$674K 0.02% 1163
2022
Q4
$1.35M Sell
290,066
-14,993
-5% -$73.9K 0.03% 884
2022
Q3
$1.43M Buy
305,059
+65,947
+28% +$416K 0.03% 698
2022
Q2
$1.42M Buy
239,112
+179,112
+299% +$1.99M 0.04% 680
2022
Q1
$1.16M Sell
60,000
-8,405
-12% -$193K 0.03% 826
2021
Q4
$2.23M Buy
68,405
+5,980
+10% +$241K 0.04% 575
2021
Q3
$2.56M Buy
62,425
+3,016
+5% +$109K 0.04% 563
2021
Q2
$2.14M Hold
59,409
0.04% 533
2021
Q1
$2.32M Sell
59,409
-69,975
-54% -$3.15M 0.05% 451
2020
Q4
$5.22M Sell
129,384
-94,168
-42% -$4.33M 0.15% 129
2020
Q3
$12.4M Buy
+223,552
New +$11.8M 0.54% 13

Other funds holding GDRX

Tudor Investment Corp's GDRX Position: Q3 2025 in Review

Tudor Investment Corp sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 24,086 shares — an estimated $120K sold.

Tudor Investment Corp first reported a position in GDRX in Q3 2020 and held it in 16 quarters. The position peaked at $12.4M in Q3 2020. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Tudor Investment Corp reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 24,086 GoodRx Holdings shares in Q3 2025, an estimated $120K.
  • Tudor Investment Corp first reported a position in GoodRx Holdings in Q3 2020 and held it in 16 quarters.
  • Tudor Investment Corp's GoodRx Holdings position peaked at $12.4M in Q3 2020.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.